<DOC>
	<DOCNO>NCT01347632</DOCNO>
	<brief_summary>This research study determine whether bacterial vaginosis ( BV ) change cervico-vaginal tissue ( skin cover cervix vagina ) make woman high risk get HIV ( Human Immunodeficiency Virus ) . Vaginal cervical tissue biopsy woman BV obtain infected OUTSIDE body ( ex vivo ) HIV . BV vaginal infection develop imbalance normal bacteria find woman 's vagina . It common cause vaginal discharge among woman child-bearing age . BV infection potentially harm safety tissue surround cervico-vaginal region . When cervico-vaginal tissue well protect , risk acquire HIV infect partner might increase significantly . Studies show HIV common woman BV woman normal vaginal bacteria . Treatment BV typically involve use antibiotic . Antibiotics kill harmful bacteria provide temporary relief symptom cause infection . Women participate study use generic antibiotic metronidazole , also know Flagyl . The Center Disease Control Prevention ( CDC ) recommend Flagyl treatment BV . The study evaluate HIV infection safety cervico-vaginal tissue woman 3 different time period : 1 . During BV infection 2 . Approximately 1 week complete 7-day course metronidazole therapy 3 . Approximately 1 month complete 7-day course metronidazole therapy You come contact HIV study - sample ( remove vagina/cervix ) come contact HIV .</brief_summary>
	<brief_title>Study How Bacterial Vaginosis Its Treatment Affects Cervical Vaginal Tissue</brief_title>
	<detailed_description>WHY ARE YOU BEING ASKED TO TAKE PART ? You ask participate research project female age 18-50 think might current BV infection ; menstrual cycle regular last two period 21-35 day apart ; willing comply procedure do 3 study visit ; willing take metronidazole 7 day . This study include people voluntarily choose take part . Please take time make decision feel free ask question might . WHAT ARE SOME IMPORTANT DETAILS ABOUT THIS STUDY ? Up approximately 80 woman expect take part study local site . There study site participate study . You three schedule visit clinic . Your participation study last approximately 2 month . WHEN SHOULD YOU NOT TAKE PART ? You take part study : - Drink alcohol daily basis unwilling abstain alcohol take metronidazole . - Have know allergy metronidazole . - Have chronic immune suppression ( include , limited , chronic steroid use , chronic anti-fungal use , Diabetes Mellitus , organ transplant ) . - Had abnormal document Pap smear past 12 month . - Had last Depo medroxyprogesterone acetate ( DMPA ) injection le 3 month ago 2 normal menses since . - Used hormonal contraceptive method within past 2 month . - Used oral vaginal antibiotic anti-fungals last 14 day . - Had surgery biopsy vulva , vagina , cervix within 30 day . - Had hysterectomy . - Were pregnant within past 3 month . - Are currently breastfeed . - Are HIV-1 positive , current sexual partner ( ) . - Use daily anti-viral suppression medication Herpes Simplex Virus ( HSV ) . - Believe currently sexually transmit infection . - Used douche vaginal product put anything vagina past 48 hour ; current presence vulvar , anal vaginal genital wart . - Have vaginal intercourse male partner within last 48 hour . - Current tobacco use . - Are currently participate another research study .</detailed_description>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Vaginal Discharge</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Be age 18 50 yearsold , inclusive ; Have current BV infection ( Nugent score 7 10 ) intermediate vaginal flora ( Nugent score 4 6 ) , diagnose Nugent score clinic ( late validation Nugent score blind separate laboratory ) ; 63 Regular menses last 2 menses 2135 day apart ; Willing able comply study procedure , include use oral treatment BV . Contraindications use oral metronidazole include : Daily alcohol consumption unable unwilling abstain alcohol take metronidazole tablet ; Known hypersensitivity oral metronidazole ; Chronic immune suppression ( include , limited chronic steroid use , chronic antifungal use , Diabetes Mellitus , organ transplant ) ; An abnormal Pap smear document past 12 month define : ASCUS without normal repeat Pap smear least 6 month later ; ASCUS positive reflex highrisk HPV testing ( ASCUS/HPV+ ) , low grade squamous epithelial lesion high grade squamous intraepithelial lesion , ASCH , atypical glandular cell , malignant cell ; It less 3 month since patient 's last Depo medroxyprogesterone acetate ( DMPA ) injection 2 normal , spontaneous menses since last use DMPA ; Use hormonal contraceptive method within past 2 month ( oral , transdermal , transvaginal , implant , hormonal intrauterine device ) ; Use oral vaginal antibiotic antifungal last 14 day ; Surgery biopsy vulva , vagina , cervix within past 30 day ; History hysterectomy ; Pregnancy within past 3 month ; Current breastfeeding ; HIV1 seropositivity participant ( history buccal HIV1 swab ) current sexual partner ( ) ; Current use antiviral suppression medication Herpes Simplex Virus ( HSV ) ( history HSV without active lesion permit ) ; Current active sexually transmit infection ( STI ) ; Presence vaginal semen last 48 hour , per patient 's report detect prostate specific antigen ( PSA ) test ; Use douche , vaginal product anything vagina past 48 hour ; Current presence vulvar , anal vaginal genital wart ; Current tobacco use ( amount ) Other condition , opinion investigator , would constitute contraindication participation study would compromise ability comply study protocol , major chronic illness include cancer , serious autoimmune disease major psychiatric disorder good control ; Current participation drug device study , study , opinion investigator , would jeopardize interpretation result study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Bacterial Vaginosis</keyword>
	<keyword>Vaginal discharge</keyword>
	<keyword>Vaginal infection</keyword>
</DOC>